Contact
searchSearch
HMP Global

August 2013 - FRMC

Foam Approved for Acne Vulgaris - Fabior™ (tazarotene) Foam, 0.1%
08/15/2013
The FDA approved tazarotene foam for acne vulgaris based on the results of two, phase 3 studies conducted in the US and Canada. 
The FDA approved tazarotene foam for acne vulgaris based on the results of two, phase 3 studies conducted in the US and Canada. 
The FDA approved tazarotene foam...
08/15/2013
First Report Managed Care
Omacetaxine Mepesuccinate for Chronic Myeloid Leukemia
08/15/2013
Tori Socha
Chicago—Of patients with chronic myeloid leukemia (CML) who are treated with tyrosine-kinase inhibitors (TKIs), 20% to 30% develop resistance to the drugs; others are intolerant.
Chicago—Of patients with chronic myeloid leukemia (CML) who are treated with tyrosine-kinase inhibitors (TKIs), 20% to 30% develop resistance to the drugs; others are intolerant.
Chicago—Of patients with chronic...
08/15/2013
First Report Managed Care
Nivolumab to Treat Advanced Melanoma
08/15/2013
Tim Casey
Chicago—After 2 years of treatment, 43% of patients with advanced melanoma who received nivolumab were alive, according to a phase 1 study. The 1-year overall survival rate was 62%, and median overall survival was 16.8 months. All patients...
Chicago—After 2 years of treatment, 43% of patients with advanced melanoma who received nivolumab were alive, according to a phase 1 study. The 1-year overall survival rate was 62%, and median overall survival was 16.8 months. All patients...
Chicago—After 2 years of...
08/15/2013
First Report Managed Care
Patient-Reported Outcomes in Patients with Multiple Myeloma
08/15/2013
Tori Socha
Chicago—A broad perspective of disease burden and impact of treatment may be gained utilizing patient-reported outcomes (PROs) such as health-related quality of life (HRQoL). For patients with multiple myeloma (MM) and other hematologic...
Chicago—A broad perspective of disease burden and impact of treatment may be gained utilizing patient-reported outcomes (PROs) such as health-related quality of life (HRQoL). For patients with multiple myeloma (MM) and other hematologic...
Chicago—A broad perspective of...
08/15/2013
First Report Managed Care
Lenvatinib for Advanced BRAF Wild-Type Melanoma
08/15/2013
Tim Casey
Chicago—At a minimum of 15 months follow-up, patients with unresectable, metastatic BRAF wild-type melanoma who received 24 mg of lenvatinib once daily had a median progression-free survival of 3.7 months and a median overall survival of 9.5...
Chicago—At a minimum of 15 months follow-up, patients with unresectable, metastatic BRAF wild-type melanoma who received 24 mg of lenvatinib once daily had a median progression-free survival of 3.7 months and a median overall survival of 9.5...
Chicago—At a minimum of 15...
08/15/2013
First Report Managed Care
Survey on Oncology Drug Shortages
08/15/2013
Tim Casey
Chicago—According to a survey, most oncologists and hematologists have faced drug shortages in recent years and have had to deny, delay, or modify treatment regimens for cancer patients. Although the scarcity of these drugs has received...
Chicago—According to a survey, most oncologists and hematologists have faced drug shortages in recent years and have had to deny, delay, or modify treatment regimens for cancer patients. Although the scarcity of these drugs has received...
Chicago—According to a survey,...
08/15/2013
First Report Managed Care
Butrans® (buprenorphine) Transdermal System and Chronic Low Back Pain
08/15/2013
Tim Casey
Patients with moderate-to-severe chronic low back pain who received 12 weeks of treatment with the Butrans® (buprenorphine) transdermal system had significant improvements in several activities of daily living compared with a placebo group.
Patients with moderate-to-severe chronic low back pain who received 12 weeks of treatment with the Butrans® (buprenorphine) transdermal system had significant improvements in several activities of daily living compared with a placebo group.
Patients with moderate-to-severe...
08/15/2013
First Report Managed Care
Opioid Usage and Diabetic Peripheral Neuropathy
08/15/2013
Tim Casey
An analysis of a claims database found that 61% of patients with diabetic peripheral neuropathy had not received treatment for the disease.Although if patients took medications, they typically used opioids to manage the condition.
An analysis of a claims database found that 61% of patients with diabetic peripheral neuropathy had not received treatment for the disease.Although if patients took medications, they typically used opioids to manage the condition.
An analysis of a claims database...
08/15/2013
First Report Managed Care
Conference Insider
Value-Based Healthcare
08/15/2013
Tim Casey
Fort Lauderdale—In the United States, approximately 100 million adults have chronic pain, which is associated with $275 billion in healthcare costs and $300 billion in lost worker productivity each year. The combined costs are larger than...
Fort Lauderdale—In the United States, approximately 100 million adults have chronic pain, which is associated with $275 billion in healthcare costs and $300 billion in lost worker productivity each year. The combined costs are larger than...
Fort Lauderdale—In the United...
08/15/2013
First Report Managed Care
Linaclotide for Treatment of IBS-C and Chronic Constipation
08/15/2013
Tori Socha
There are limited options available for the treatment of irritable bowel syndrome with constipation, but linaclotide has recently been approved.
There are limited options available for the treatment of irritable bowel syndrome with constipation, but linaclotide has recently been approved.
There are limited options...
08/15/2013
First Report Managed Care
Linaclotide and Sexual Subscale Scores on IBS-QOL
08/15/2013
Tori Socha
Irritable bowel syndrome (chronic functional gastrointestinal disorder) causes low quality of life and psychosocial wellbeing, and decreased sexual desire.
Irritable bowel syndrome (chronic functional gastrointestinal disorder) causes low quality of life and psychosocial wellbeing, and decreased sexual desire.
Irritable bowel...
08/15/2013
First Report Managed Care
Patient-Reported Outcomes in Assessing IBS Severity
08/15/2013
Tori Socha
  Orlando—Characterizing the therapeutic benefit of novel agents for irritable bowel syndrome relies heavily on patient-reported outcomes (PROs) assessing multiple gastrointestinal symptoms. Common approaches that sum or average responses...
  Orlando—Characterizing the therapeutic benefit of novel agents for irritable bowel syndrome relies heavily on patient-reported outcomes (PROs) assessing multiple gastrointestinal symptoms. Common approaches that sum or average responses...
  Orlando—Characterizing the...
08/15/2013
First Report Managed Care
Conference Insider
Trends in Ambulatory Care for IBS, 1993-2010
08/15/2013
Tori Socha
Researchers conducted a study to identify trends in IBS-related physician visits, evaluation, and management in the United States over the past 2 decades.
Researchers conducted a study to identify trends in IBS-related physician visits, evaluation, and management in the United States over the past 2 decades.
Researchers conducted a study to...
08/15/2013
First Report Managed Care
Patient-Physician Interactions: Patients with IBS
08/15/2013
Tori Socha
Previous studies have demonstrated that an effective patient-physician relationship can improve clinical outcomes in patients with irritable bowel syndrome (IBS).
Previous studies have demonstrated that an effective patient-physician relationship can improve clinical outcomes in patients with irritable bowel syndrome (IBS).
Previous studies have...
08/15/2013
First Report Managed Care
Phentermine and Topiramate for Patients with Dysglycemia
08/15/2013
Tim Casey
Chicago—Obese or overweight adults with dysglycemia who received phentermine and topiramate extended-release pills had a mean weight loss of 7.7% to 11.6% after 56 weeks of treatment, according to a post hoc analysis of a randomized,...
Chicago—Obese or overweight adults with dysglycemia who received phentermine and topiramate extended-release pills had a mean weight loss of 7.7% to 11.6% after 56 weeks of treatment, according to a post hoc analysis of a randomized,...
Chicago—Obese or overweight...
08/15/2013
First Report Managed Care
Linagliptin and Cardiovascular Risk
08/15/2013
Tim Casey
Chicago—Patients with type 2 diabetes who took linagliptin were not at higher risk of having cardiovascular events compared with patients who took other drugs, according to an analysis of 19 multicenter, randomized, double-blind, parallel...
Chicago—Patients with type 2 diabetes who took linagliptin were not at higher risk of having cardiovascular events compared with patients who took other drugs, according to an analysis of 19 multicenter, randomized, double-blind, parallel...
Chicago—Patients with type 2...
08/15/2013
First Report Managed Care
Pooled Data Analysis of Canagliflozin
08/15/2013
Tim Casey
Chicago—Compared with a group receiving placebo, patients with type 2 diabetes who took 100 mg or 300 mg of canagliflozin had improvements in glycemic control and reductions in body weight, according to a pooled data analysis of 4 randomized,...
Chicago—Compared with a group receiving placebo, patients with type 2 diabetes who took 100 mg or 300 mg of canagliflozin had improvements in glycemic control and reductions in body weight, according to a pooled data analysis of 4 randomized,...
Chicago—Compared with a group...
08/15/2013
First Report Managed Care
Conference Insider
Analysis of a Veterans Affairs Lifestyle Change Program
08/15/2013
Tim Casey
Chicago—An analysis of a large lifestyle change program in patients with type 2 diabetes found that diet and exercise modification can help patients, although <10% of participants were actively involved in the program. Sandra L. Jackson,...
Chicago—An analysis of a large lifestyle change program in patients with type 2 diabetes found that diet and exercise modification can help patients, although <10% of participants were actively involved in the program. Sandra L. Jackson,...
Chicago—An analysis of a large...
08/15/2013
First Report Managed Care
Investigational Agent Dulaglutide versus Exenatide and Placebo
08/15/2013
Tim Casey
Chicago—After 26 weeks of treatment, patients with type 2 diabetes who received dulaglutide once weekly had a statistically significant reduction in hemoglobin A1c (HbA1c) levels compared with a placebo group and patients who took exenatide,...
Chicago—After 26 weeks of treatment, patients with type 2 diabetes who received dulaglutide once weekly had a statistically significant reduction in hemoglobin A1c (HbA1c) levels compared with a placebo group and patients who took exenatide,...
Chicago—After 26 weeks of...
08/15/2013
First Report Managed Care
Combination of Liraglutide and Insulin Degludec
08/15/2013
Tim Casey
Chicago—According to a randomized, open-label, phase 3 trial, patients with type 2 diabetes who received a combination of liraglutide and insulin degludec had significant reductions in hemoglobin A1c (HbA1c) levels after 26 weeks compared...
Chicago—According to a randomized, open-label, phase 3 trial, patients with type 2 diabetes who received a combination of liraglutide and insulin degludec had significant reductions in hemoglobin A1c (HbA1c) levels after 26 weeks compared...
Chicago—According to a...
08/15/2013
First Report Managed Care
Albiglutide Injection to Treat Type 2 Diabetes
08/15/2013
Tim Casey
Chicago—After 104 weeks of treatment, patients with type 2 diabetes who received albiglutide in combination with metformin had statistically and clinically significant glucose reductions compared with patients who took sitagliptin,...
Chicago—After 104 weeks of treatment, patients with type 2 diabetes who received albiglutide in combination with metformin had statistically and clinically significant glucose reductions compared with patients who took sitagliptin,...
Chicago—After 104 weeks of...
08/15/2013
First Report Managed Care
Management Strategies for Obese Patients with Type 2 Diabetes
08/14/2013
Tim Casey
A trial of obese patients with type 2 diabetes found that Roux-en-Y gastric bypass surgery had greater weight loss than management programs. 
A trial of obese patients with type 2 diabetes found that Roux-en-Y gastric bypass surgery had greater weight loss than management programs. 
A trial of obese patients with...
08/14/2013
First Report Managed Care
News Connection
Coverage of ED Visits for Young Adults under the ACA
08/14/2013
Tori Socha
One of the provisions of the Patient Protection and Affordable Care Act (ACA) became effective on September 23, 2010. As of that date and in all states, all adults between 19 and 25 years of age are eligible for health insurance coverage...
One of the provisions of the Patient Protection and Affordable Care Act (ACA) became effective on September 23, 2010. As of that date and in all states, all adults between 19 and 25 years of age are eligible for health insurance coverage...
One of the provisions of the...
08/14/2013
First Report Managed Care
News Connection
Mobile Acute Care of the Elderly Service Model Improves Outcomes
08/14/2013
Tori Socha
Older adults admitted to the hospital for acute medical problems are at risk for adverse events both during and after the hospitalization. Possible events include pressure ulcers, falls, hospital-acquired infections, functional decline,...
Older adults admitted to the hospital for acute medical problems are at risk for adverse events both during and after the hospitalization. Possible events include pressure ulcers, falls, hospital-acquired infections, functional decline,...
Older adults admitted to the...
08/14/2013
First Report Managed Care
Oncology Clinical Trials: Analysis of ClinicalTrials.gov
08/14/2013
Tori Socha
Noting a lack of data required to correctly identify the characteristics of current oncology trials and the ability of those trials to advance care, researchers recently conducted a comprehensive analysis of the national oncology clinical...
Noting a lack of data required to correctly identify the characteristics of current oncology trials and the ability of those trials to advance care, researchers recently conducted a comprehensive analysis of the national oncology clinical...
Noting a lack of data required...
08/14/2013
First Report Managed Care
Diagnosing Sarcoidosis: Endosonography versus Bronchoscopy
08/14/2013
Tori Socha
The incidence of sarcoidosis, a multisystem granulomatous disease of unclear etiology, is, according to researchers, high, with up to 40 cases per 100,000 individuals. In addition, mortality related to sarcoidosis is increasing. The disease...
The incidence of sarcoidosis, a multisystem granulomatous disease of unclear etiology, is, according to researchers, high, with up to 40 cases per 100,000 individuals. In addition, mortality related to sarcoidosis is increasing. The disease...
The incidence of sarcoidosis, a...
08/14/2013
First Report Managed Care
News Connection
Kaiser: Medicare Advantage 2013 Spotlight
08/14/2013


Warning: Invalid argument supplied for foreach() in /home/hmpmcc/public_html/includes/module.inc on line 1118
Tori Socha

Warning: Invalid argument supplied f...
Despite concerns that the Patient Protection and Affordable Care Act would lead to reductions in Medicare Advantage (MA) plan enrollments, 14.4 million Americans were enrolled in a MA plan as of March 2013, an increase of >12 million over...
Despite concerns that the Patient Protection and Affordable Care Act would lead to reductions in Medicare Advantage (MA) plan enrollments, 14.4 million Americans were enrolled in a MA plan as of March 2013, an increase of >12 million over...
Despite concerns that the...
08/14/2013
First Report Managed Care
Management of Patients with Parkinson Disease via Telemedicine
08/14/2013
Tori Socha
For patients with Parkinson disease (PD), access to care may be limited by distance, disability, and distribution of physicians. It is estimated that 40% of Medicare beneficiaries with PD have not seen a neurologist.
For patients with Parkinson disease (PD), access to care may be limited by distance, disability, and distribution of physicians. It is estimated that 40% of Medicare beneficiaries with PD have not seen a neurologist.
For patients with Parkinson...
08/14/2013
First Report Managed Care
Prostate-Specific Antigen Screening in Older Men
08/14/2013
Tori Socha
Prostate-specific antigen (PSA) screening in older men, including those with serious comorbidity, is common practice in spite of recommendations against PSA screening in that population. The recommendations against PSA screening in men with...
Prostate-specific antigen (PSA) screening in older men, including those with serious comorbidity, is common practice in spite of recommendations against PSA screening in that population. The recommendations against PSA screening in men with...
Prostate-specific antigen (PSA)...
08/14/2013
First Report Managed Care
Nighttime Intensivist Staffing in a Medical ICU
08/14/2013
Tori Socha
Studies show that intensivist physicians improve patient outcomes in intensive care units (ICUs).
Studies show that intensivist physicians improve patient outcomes in intensive care units (ICUs).
Studies show that intensivist...
08/14/2013
First Report Managed Care
Advance Care Planning for the End of Life
08/14/2013
Tori Socha
According to researchers, most elderly patients prefer only comfort measures at the end of life (EOL); however, clinicians are increasingly using life-sustaining technologies in a patient’s final stages. Whereas most people express a desire...
According to researchers, most elderly patients prefer only comfort measures at the end of life (EOL); however, clinicians are increasingly using life-sustaining technologies in a patient’s final stages. Whereas most people express a desire...
According to researchers, most...
08/14/2013
First Report Managed Care
IMRT versus CRT after Prostatectomy
08/14/2013
Tori Socha
The most common malignant neoplasm in American men is prostate cancer; there are 240,000 cases of prostate cancer and 30,000 deaths from the disease per year. Emerging technologies such as intensity-modulated radiotherapy (IMRT) have been...
The most common malignant neoplasm in American men is prostate cancer; there are 240,000 cases of prostate cancer and 30,000 deaths from the disease per year. Emerging technologies such as intensity-modulated radiotherapy (IMRT) have been...
The most common malignant...
08/14/2013
First Report Managed Care
News Connection
AMA Focuses on Physician Satisfaction
08/14/2013
Tim Casey
Soon after the American Medical Association (AMA) announced last year its plan to enhance physician satisfaction and practice sustainability, AMA chief executive officer James Madara, MD, received complaints from outside the medical...
Soon after the American Medical Association (AMA) announced last year its plan to enhance physician satisfaction and practice sustainability, AMA chief executive officer James Madara, MD, received complaints from outside the medical...
Soon after the American Medical...
08/14/2013
First Report Managed Care
News Connection
Wellness and Incentives Improve Health, Lower Costs
08/14/2013
Tim Casey
Through his academic training and work experience, Shivan Mehta, MD, MBA, understands better than most people the clinical and business aspects of medicine. Dr. Mehta, a practicing gastroenterologist, is also director of operations at the...
Through his academic training and work experience, Shivan Mehta, MD, MBA, understands better than most people the clinical and business aspects of medicine. Dr. Mehta, a practicing gastroenterologist, is also director of operations at the...
Through his academic training...
08/14/2013
First Report Managed Care

Behind the Bill

Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care
BEHIND THE BILL
When Agencies Lose Power: How 3 Seismic Shifts are Transforming Pharmaceutical Regulation
05/07/2025
Katie Hayes, MJ
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months,...
05/07/2025
First Report Managed Care
Behind the Bill
The Medicare Paradox, Part 3: Strategic Trade Doesn’t Have to be a Zero-Sum Game
05/07/2025
Katie Hayes, MJ
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve...
05/07/2025
First Report Managed Care

Trending Articles

News
FTC and HHS Launch Joint Inquiry into Generic Drug Shortages: Seeking Public Input on GPOs and Wholesalers
02/16/2024
Danielle Sposato
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on February 14, 2024, the US Department of Health and Human Services (HHS) issued a "Request for Information" in collaboration with the Federal Trade Commission (FTC). This request aims to gain insight into how...
In a news release published on...
02/16/2024
First Report Managed Care
Julie Schulz headshot
Commentary
How Lab Values Can Close the Gap Between Patients With Undiagnosed and Under-Staged Chronic Kidney Disease
03/27/2024

By Julie Schulz, MD, MPH

By Julie Schulz, MD, MPH
Chronic kidney disease (CKD) is an insidious condition with devastating consequences when detected and treated too late. While primary care physicians usually make the initial diagnosis, regular screening is not routine for the general...
Chronic kidney disease (CKD) is an insidious condition with devastating consequences when detected and treated too late. While primary care physicians usually make the initial diagnosis, regular screening is not routine for the general...
Chronic kidney disease (CKD) is...
03/27/2024
First Report Managed Care
News
Neurologist Recognized for Pioneering MS Research and Treatment Strategies
04/24/2024
Hannah Musick
Dr Rhonda Voskuhl received the 2024 John Dystel prize for her groundbreaking research on sex differences in multiple sclerosis (MS), advancing women's health.
Dr Rhonda Voskuhl received the 2024 John Dystel prize for her groundbreaking research on sex differences in multiple sclerosis (MS), advancing women's health.
Dr Rhonda Voskuhl received the...
04/24/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
News
Challenges and Progress in Understanding and Combating Respiratory Syncytial Virus Infection
07/02/2024
Hannah Musick
While challenges such as vaccine safety, immunogenicity, and durability remain, ongoing research and clinical trials show promise for the development of effective RSV vaccines in the near future according to research compiled in the Official...
While challenges such as vaccine safety, immunogenicity, and durability remain, ongoing research and clinical trials show promise for the development of effective RSV vaccines in the near future according to research compiled in the Official...
While challenges such as vaccine...
07/02/2024
First Report Managed Care

August 2013 Volume 10 Issue 8

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use